Ensysce Biosciences Prices $5 Million Registered Direct Offering

MT Newswires Live08-29

Ensysce Biosciences (ENSC) said Thursday it has entered into agreements for a $5 million registered direct offering involving the sale of about 3.6 million common shares at $0.47 apiece.

The company said it has agreed to exercise warrants issued in February for the purchase of up to roughly 7.2 million shares at a lower price of $0.47 per share versus $1.06 apiece set previously.

In a concurrent private placement, Ensysce will issue unregistered Series A-3 and Series A-4 warrants to purchase up to roughly 14.4 million shares at the same price, the company said, adding that the offering will likely close around Thursday, it added.

Ensysce also said it plans to use the net proceeds to advance its TAAP and MPAR programs and for general working capital, supplementing a recent $14 million NIH grant for its PF614-MPAR program.

The company's shares were down more than 32% in recent Thursday premarket activity.

Price: 0.4200, Change: -0.21, Percent Change: -32.93

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2463531222?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-08-29 20:59","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2463531222","market":"sh","top_or_hot":-1,"title":"Ensysce Biosciences Prices $5 Million Registered Direct Offering","media":"MT Newswires Live","content":"<html><body><p> Ensysce Biosciences (ENSC) said Thursday it has entered into agreements for a $5 million registered direct offering involving the sale of about 3.6 million common shares at $0.47 apiece.</p><p>The company said it has agreed to exercise warrants issued in February for the purchase of up to roughly 7.2 million shares at a lower price of $0.47 per share versus $1.06 apiece set previously.</p><p>In a concurrent private placement, Ensysce will issue unregistered Series A-3 and Series A-4 warrants to purchase up to roughly 14.4 million shares at the same price, the company said, adding that the offering will likely close around Thursday, it added.</p><p>Ensysce also said it plans to use the net proceeds to advance its TAAP and MPAR programs and for general working capital, supplementing a recent $14 million NIH grant for its PF614-MPAR program.</p><p>The company's shares were down more than 32% in recent Thursday premarket activity.</p><p>Price: 0.4200, Change: -0.21, Percent Change: -32.93</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Ensysce Biosciences Prices $5 Million Registered Direct Offering</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEnsysce Biosciences Prices $5 Million Registered Direct Offering\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-08-29 20:59 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.mtnewswires.com/><strong>MT Newswires Live</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Ensysce Biosciences (ENSC) said Thursday it has entered into agreements for a $5 million registered direct offering involving the sale of about 3.6 million common shares at $0.47 apiece.The company ...</p>\n\n<a href=\"https://www.mtnewswires.com/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2463531222","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2463531222","pubTimestamp":1724936374,"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Ensysce Biosciences  said Thursday it has entered into agreements for a $5 million registered direct offering involving the sale of about 3.6 million common shares at $0.47 apiece.The company said it has agreed to exercise warrants issued in February for the purchase of up to roughly 7.2 million shares at a lower price of $0.47 per share versus $1.06 apiece set previously.In a concurrent private placement, Ensysce will issue unregistered Series A-3 and Series A-4 warrants to purchase up to roughly 14.4 million shares at the same price, the company said, adding that the offering will likely close around Thursday, it added.Ensysce also said it plans to use the net proceeds to advance its TAAP and MPAR programs and for general working capital, supplementing a recent $14 million NIH grant for its PF614-MPAR program.The company's shares were down more than 32% in recent Thursday premarket activity.Price: 0.4200, Change: -0.21, Percent Change: -32.93","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4139":"生物科技","ENSC":"Ensysce Biosciences Inc."},"translate_title":"Ensysce Biosciences注册直接发行定价500万美元","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ENSC":0.9},"content_text":"Ensysce Biosciences (ENSC) said Thursday it has entered into agreements for a $5 million registered direct offering involving the sale of about 3.6 million common shares at $0.47 apiece.The company said it has agreed to exercise warrants issued in February for the purchase of up to roughly 7.2 million shares at a lower price of $0.47 per share versus $1.06 apiece set previously.In a concurrent private placement, Ensysce will issue unregistered Series A-3 and Series A-4 warrants to purchase up to roughly 14.4 million shares at the same price, the company said, adding that the offering will likely close around Thursday, it added.Ensysce also said it plans to use the net proceeds to advance its TAAP and MPAR programs and for general working capital, supplementing a recent $14 million NIH grant for its PF614-MPAR program.The company's shares were down more than 32% in recent Thursday premarket activity.Price: 0.4200, Change: -0.21, Percent Change: -32.93","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.28.3","shortVersion":"4.28.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2463531222"}